Nifty
Sensex
:
:
13258.55
45079.55
124.65 (0.95%)
446.90 (1.00%)

Pharmaceuticals & Drugs - Global

Rating :
61/99  (View)

BSE: 532300 | NSE: WOCKPHARMA

442.10
-1.35 (-0.30%)
04-Dec-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  443.50
  •  458.00
  •  439.10
  •  443.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  665492
  •  2942.14
  •  473.00
  •  146.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,897.12
  • 5.96
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,841.89
  • N/A
  • 1.42

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.12%
  • 1.02%
  • 19.94%
  • FII
  • DII
  • Others
  • 4.63%
  • 0.01%
  • 2.28%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.20
  • -5.67
  • -5.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -12.42
  • -13.23
  • 165.87

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.76
  • -
  • -51.54

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.44
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.95
  • 2.13
  • 1.78

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 49.26
  • 72.42
  • 61.65

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
714
683
5%
598
726
-18%
687
861
-20%
869
1,046
-17%
Expenses
697
670
4%
670
726
-8%
681
848
-20%
760
1,064
-29%
EBITDA
17
13
30%
-72
0
-
6
13
-55%
109
-18
-
EBIDTM
2%
2%
-12%
0%
14%
14%
13%
-2%
Other Income
16
0
-
8
8
-2%
21
26
-19%
42
2
1932%
Interest
61
65
-6%
74
71
4%
61
64
-3%
79
64
24%
Depreciation
57
52
9%
56
55
3%
61
45
36%
56
41
36%
PBT
-85
-105
-
-336
-118
-
-95
-69
-
16
-121
-
Tax
-88
12
-
-111
-55
-
-144
-41
-
-3
-44
-
PAT
3
-116
-
-226
-63
-
49
-27
-
19
-77
-
PATM
0%
-17%
-38%
-9%
7%
7%
2%
-7%
EPS
0.30
-10.50
-
-20.36
-5.67
-
4.40
-2.47
-
1.73
-6.94
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
2,868
3,325
4,158
3,937
4,015
4,453
4,482
4,830
5,609
4,350
3,751
Net Sales Growth
-13%
-20%
6%
-2%
-10%
-1%
-7%
-14%
29%
16%
 
Cost Of Goods Sold
5,505
1,203
1,636
1,798
1,662
1,614
1,487
1,806
1,748
1,534
1,516
Gross Profit
-2,637
2,122
2,522
2,139
2,353
2,840
2,994
3,024
3,862
2,816
2,235
GP Margin
-92%
64%
61%
54%
59%
64%
67%
63%
69%
65%
60%
Total Expenditure
2,809
3,082
4,051
3,935
3,988
3,959
3,772
3,805
3,550
2,997
2,835
Power & Fuel Cost
-
85
93
78
110
114
101
92
97
80
56
% Of Sales
-
3%
2%
2%
3%
3%
2%
2%
2%
2%
1%
Employee Cost
-
743
800
937
967
951
869
769
656
573
542
% Of Sales
-
22%
19%
24%
24%
21%
19%
16%
12%
13%
14%
Manufacturing Exp.
-
121
154
135
179
228
236
241
180
115
111
% Of Sales
-
4%
4%
3%
4%
5%
5%
5%
3%
3%
3%
General & Admin Exp.
-
188
380
477
504
406
321
352
248
194
199
% Of Sales
-
6%
9%
12%
13%
9%
7%
7%
4%
4%
5%
Selling & Distn. Exp.
-
141
176
209
205
241
262
293
292
215
186
% Of Sales
-
4%
4%
5%
5%
5%
6%
6%
5%
5%
5%
Miscellaneous Exp.
-
600
811
302
361
406
496
252
329
285
186
% Of Sales
-
18%
19%
8%
9%
9%
11%
5%
6%
7%
6%
EBITDA
60
243
108
2
26
494
709
1,026
2,060
1,354
916
EBITDA Margin
2%
7%
3%
0%
1%
11%
16%
21%
37%
31%
24%
Other Income
88
60
21
120
101
66
67
38
54
25
153
Interest
275
276
265
255
225
129
55
83
215
269
267
Depreciation
230
224
164
150
149
142
145
140
122
115
117
PBT
-500
-197
-300
-283
-247
289
575
841
1,776
995
685
Tax
-346
-153
-84
26
-21
38
163
48
258
222
9
Tax Rate
69%
78%
28%
-4%
9%
13%
28%
5%
14%
43%
8%
PAT
-154
-69
-195
-608
-196
250
405
841
1,579
299
96
PAT before Minority Interest
-163
-43
-217
-667
-226
252
413
843
1,579
299
96
Minority Interest
-9
-26
22
59
30
-2
-8
-2
0
0
0
PAT Margin
-5%
-2%
-5%
-15%
-5%
6%
9%
17%
28%
7%
3%
PAT Growth
0%
64%
68%
-211%
-178%
-38%
-52%
-47%
427%
213%
 
EPS
-13.93
-6.25
-17.56
-54.90
-17.66
22.57
36.54
75.88
142.55
27.03
8.64

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
2,672
2,675
2,852
3,337
3,775
3,715
3,581
2,704
1,471
943
Share Capital
55
55
55
55
55
354
353
353
816
800
Total Reserves
2,586
2,587
2,760
3,244
3,691
3,316
3,183
2,319
645
143
Non-Current Liabilities
1,195
1,703
2,089
3,151
1,893
1,872
1,161
1,521
2,892
2,944
Secured Loans
1,237
1,653
2,168
2,887
1,647
1,180
1,096
1,468
2,697
2,785
Unsecured Loans
3
238
5
303
273
5
6
8
9
9
Long Term Provisions
46
53
65
94
71
635
52
70
84
224
Current Liabilities
3,497
2,864
2,692
1,979
1,842
1,773
1,743
1,773
1,891
1,919
Trade Payables
895
840
602
534
638
553
558
634
541
437
Other Current Liabilities
1,580
1,353
1,548
690
621
844
948
790
978
1,069
Short Term Borrowings
904
562
437
663
550
348
210
182
261
390
Short Term Provisions
118
109
105
92
33
28
28
167
111
24
Total Liabilities
7,749
7,571
7,978
8,849
7,976
7,505
6,622
5,998
6,254
5,806
Net Block
3,502
3,058
2,888
2,773
2,809
2,123
2,295
1,990
2,571
2,580
Gross Block
6,703
6,113
5,772
5,456
4,377
4,553
4,643
4,296
4,212
4,049
Accumulated Depreciation
3,201
3,055
2,884
2,684
1,568
2,430
2,348
1,685
1,307
1,439
Non Current Assets
5,320
4,756
4,599
4,314
4,024
3,983
3,266
2,672
3,772
3,904
Capital Work in Progress
1,585
1,445
1,433
1,244
1,036
1,007
708
491
902
863
Non Current Investment
0
0
0
0
0
3
3
3
91
90
Long Term Loans & Adv.
232
252
278
297
179
846
236
183
208
371
Other Non Current Assets
0
0
0
0
0
5
25
5
0
0
Current Assets
2,430
2,815
3,380
4,535
3,952
3,522
3,356
3,327
2,482
1,902
Current Investments
0
0
213
562
0
339
574
0
0
0
Inventories
690
819
856
1,108
1,102
1,021
993
1,059
889
714
Sundry Debtors
1,243
1,274
962
1,034
1,111
741
481
958
759
605
Cash & Bank
268
449
1,082
1,604
1,478
1,235
1,126
1,096
700
483
Other Current Assets
229
20
8
29
260
186
182
214
134
100
Short Term Loans & Adv.
163
253
258
198
260
186
182
214
134
100
Net Current Assets
-1,067
-49
688
2,556
2,110
1,749
1,613
1,553
591
-17
Total Assets
7,749
7,571
7,978
8,849
7,976
7,505
6,622
5,998
6,254
5,806

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
649
183
68
-269
72
355
1,476
1,532
1,344
642
PBT
-197
-300
-641
-247
357
575
891
1,860
577
104
Adjustment
483
445
449
303
201
286
134
273
918
495
Changes in Working Capital
380
80
278
-297
-403
-345
588
-267
-130
45
Cash after chg. in Working capital
666
224
86
-242
156
516
1,612
1,867
1,364
645
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-17
-41
-18
-28
-84
-161
-136
-334
-21
-3
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-156
95
630
-687
-818
-207
-852
1,085
-305
-277
Net Fixed Assets
-500
-39
-46
-167
-368
-300
-284
174
-182
-415
Net Investments
0
0
0
0
0
11
0
0
0
8
Others
344
134
676
-520
-450
83
-568
911
-124
131
Cash from Financing Activity
-680
-776
-769
1,254
254
-76
-601
-2,246
-827
-373
Net Cash Inflow / Outflow
-186
-499
-71
298
-492
73
23
372
212
-8
Opening Cash & Equivalents
397
897
964
663
1,159
1,102
1,050
690
470
314
Closing Cash & Equivalent
219
397
897
964
665
1,159
1,102
1,050
690
470

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
239
239
254
299
339
306
295
217
64
18
ROA
-1%
-3%
-8%
-3%
3%
6%
13%
26%
5%
2%
ROE
-2%
-8%
-22%
-6%
7%
12%
30%
103%
67%
95%
ROCE
1%
-1%
-5%
0%
7%
11%
19%
43%
17%
8%
Fixed Asset Turnover
0.52
0.70
0.70
0.82
1.00
0.98
1.08
1.32
1.05
0.95
Receivable days
138
98
93
98
76
50
54
56
57
57
Inventory Days
83
74
91
100
87
82
77
63
67
72
Payable days
130
87
67
64
65
64
65
65
66
63
Cash Conversion Cycle
91
85
116
134
98
68
67
54
59
66
Total Debt/Equity
1.22
1.28
1.33
1.26
0.71
0.55
0.54
0.77
2.25
3.60
Interest Cover
0
0
-2
0
3
11
12
10
3
1

News Update


  • Wockhardt turns black in Q2
    2nd Nov 2020, 16:46 PM

    Total income of the company increased by 6.97% at Rs 730.29 crore for Q2FY21

    Read More
  • Wockhardt turns black in Q1
    31st Aug 2020, 15:54 PM

    Total income of the company decreased by 17.37% at Rs 606.22 crore for Q1FY21

    Read More
  • Wockhardt - Quarterly Results
    29th Aug 2020, 12:56 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.